4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001193125-26-023094
Chief Operating Officer acquired 190,376 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sattarzadeh Sherwin · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-05 | Grant or award : show line 1 in the form | +190,376 | 190,376 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-05 | Grant or award : show line 2 in the form Stock Option (right to buy) | +444,209 | 444,209 | D |
Loading xslF345X05/ownership.xml…